Home/Filings/4/0001209191-20-035783
4//SEC Filing

Halfon Jean Michel 4

Accession 0001209191-20-035783

CIK 0000818686other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 7:12 AM ET

Size

5.8 KB

Accession

0001209191-20-035783

Insider Transaction Report

Form 4
Period: 2020-06-09
Transactions
  • Award

    Restricted Share Units

    2020-06-09+12,66812,668 total
    Ordinary Shares (12,668 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Restricted share units were granted on June 9, 2020 and vest on June 9, 2021.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001721516

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 7:12 AM ET
Size
5.8 KB